Compliance Rate
Compliance Rate
52.0%
Compliant submissions
52
Incompliant submissions
48
Total trials
100
Your Clinical Trials
Showing 25 of 100 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/06/22
End: 01/08/22
Due: 01/09/22
Phase: N/A
Priority: Normal
Start: 01/16/22
End: 01/18/22
Due: 01/19/22
Phase: N/A
Priority: Normal
Start: 01/26/22
End: 01/28/22
Due: 01/29/22
Phase: N/A
Priority: Normal
Start: 02/05/22
End: 02/07/22
Due: 02/08/22
Phase: N/A
Priority: Normal
Start: 02/15/22
End: 02/17/22
Due: 02/18/22
Phase: N/A
Priority: Normal
Start: 02/25/22
End: 02/27/22
Due: 02/28/22
Phase: N/A
Priority: Normal
Start: 03/07/22
End: 03/09/22
Due: 03/10/22
Phase: N/A
Priority: Normal
Start: 03/17/22
End: 03/19/22
Due: 03/20/22
Phase: N/A
Priority: Normal
Start: 03/27/22
End: 03/29/22
Due: 03/30/22
Phase: N/A
Priority: Normal
Start: 04/06/22
End: 04/08/22
Due: 04/09/22
Phase: N/A
Priority: Normal
Start: 06/15/22
End: 06/17/22
Due: 06/18/22
Phase: N/A
Priority: Normal
Start: 07/05/22
End: 07/07/22
Due: 07/08/22
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 01/03/23
Due: 01/04/23
Phase: N/A
Priority: Normal
Start: 09/18/23
End: 09/20/23
Due: 09/21/23
Phase: N/A
Priority: Normal
Start: 07/24/24
End: 07/26/24
Due: 07/27/24
Phase: N/A
Priority: Normal
Start: 07/31/86
End: 03/31/94
Due: 03/31/95
Phase: N/A
Priority: Normal
Start: 05/31/97
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: -
End: 09/30/96
Due: 09/30/97
Phase: N/A
Priority: Normal
Start: -
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: 03/31/97
End: 04/30/01
Due: 04/30/02
Phase: N/A
Priority: Normal
Start: -
End: 06/30/00
Due: 06/30/01
Phase: N/A
Priority: Normal
Start: 09/30/82
End: 09/30/85
Due: 09/30/86
Phase: N/A
Priority: Normal
Start: -
End: 08/31/00
Due: 08/31/01
Phase: N/A
Priority: Normal
Start: 02/28/93
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/71
End: 11/30/76
Due: 11/30/77
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study 5 | NCT00000004 | Organization 5 | user5@example.com | Incompliant | 2022-01-06 | 2022-01-08 | 2022-01-09 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 15 | NCT00000014 | Organization 15 | user5@example.com | Compliant | 2022-01-16 | 2022-01-18 | 2022-01-19 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 25 | NCT00000024 | Organization 25 | user5@example.com | Incompliant | 2022-01-26 | 2022-01-28 | 2022-01-29 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 35 | NCT00000034 | Organization 35 | user5@example.com | Incompliant | 2022-02-05 | 2022-02-07 | 2022-02-08 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 45 | NCT00000044 | Organization 45 | user5@example.com | Incompliant | 2022-02-15 | 2022-02-17 | 2022-02-18 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 55 | NCT00000054 | Organization 55 | user5@example.com | Incompliant | 2022-02-25 | 2022-02-27 | 2022-02-28 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 65 | NCT00000064 | Organization 65 | user5@example.com | Compliant | 2022-03-07 | 2022-03-09 | 2022-03-10 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 75 | NCT00000074 | Organization 75 | user5@example.com | Incompliant | 2022-03-17 | 2022-03-19 | 2022-03-20 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 85 | NCT00000084 | Organization 85 | user5@example.com | Compliant | 2022-03-27 | 2022-03-29 | 2022-03-30 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 95 | NCT00000094 | Organization 95 | user5@example.com | Compliant | 2022-04-06 | 2022-04-08 | 2022-04-09 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 165 | NCT00000164 | Organization 65 | user5@example.com | Compliant | 2022-06-15 | 2022-06-17 | 2022-06-18 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 185 | NCT00000184 | Organization 85 | user5@example.com | Compliant | 2022-07-05 | 2022-07-07 | 2022-07-08 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 365 | NCT00000364 | Organization 65 | user5@example.com | Compliant | 2023-01-01 | 2023-01-03 | 2023-01-04 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 625 | NCT00000624 | Organization 25 | user5@example.com | Incompliant | 2023-09-18 | 2023-09-20 | 2023-09-21 | 2025-07-01 | Monitor | 2025-07-01 |
| Study 935 | NCT00000934 | Organization 35 | user5@example.com | Compliant | 2024-07-24 | 2024-07-26 | 2024-07-27 | 2025-07-01 | Monitor | 2025-07-01 |
| Myocarditis Treatment Trial | NCT00000524 | University of Utah | user5@example.com | Compliant | 1986-07-31 | 1994-03-31 | 1995-03-31 | 2025-07-01 | - | 2025-07-14 |
| Treatment of Obsessive-Compulsive Disorder (OCD) in Children | NCT00000384 | University of Pennsylvania | user5@example.com | Compliant | 1997-05-31 | 2002-04-30 | 2003-04-30 | 2025-07-01 | - | 2025-07-14 |
| A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia | NCT00000974 | National Institute of Allergy and Infectious Diseases (NIAID) | user5@example.com | Compliant | - | 1996-09-30 | 1997-09-30 | 2025-07-01 | - | 2025-07-14 |
| An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies | NCT00000714 | National Institute of Allergy and Infectious Diseases (NIAID) | user5@example.com | Incompliant | - | 2004-07-31 | 2005-07-31 | 2025-07-01 | - | 2025-07-14 |
| Tryptophan and Behavior Therapy for Cocaine Abuse - 1 | NCT00000324 | National Institute on Drug Abuse (NIDA) | user5@example.com | Incompliant | 1997-03-31 | 2001-04-30 | 2002-04-30 | 2025-07-01 | - | 2025-07-14 |
| A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks | NCT00000914 | National Institute of Allergy and Infectious Diseases (NIAID) | user5@example.com | Incompliant | - | 2000-06-30 | 2001-06-30 | 2025-07-01 | - | 2025-07-14 |
| Cardiac Arrhythmia Pilot Study (CAPS) | NCT00000504 | National Heart, Lung, and Blood Institute (NHLBI) | user5@example.com | Compliant | 1982-09-30 | 1985-09-30 | 1986-09-30 | 2025-07-01 | - | 2025-07-14 |
| Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 | NCT00000344 | National Institute on Drug Abuse (NIDA) | user5@example.com | Compliant | - | 2000-08-31 | 2001-08-31 | 2025-07-01 | - | 2025-07-14 |
| Alternate-Day Buprenorphine. Phase V - 6 | NCT00000224 | National Institute on Drug Abuse (NIDA) | user5@example.com | Incompliant | 1993-02-28 | - | - | 2025-07-01 | - | 2025-07-14 |
| NHLBI Type II Coronary Intervention Study | NCT00000594 | National Heart, Lung, and Blood Institute (NHLBI) | user5@example.com | Incompliant | 1971-11-30 | 1976-11-30 | 1977-11-30 | 2025-07-01 | - | 2025-07-14 |